Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Alvotech - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
ALVO
Nasdaq
2830
www.alvotech.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Alvotech
Alvotech Hits Critical Inflection as Biosimilar Pipeline Nears FDA Decisions
- Jun 10th, 2026 1:02 pm
Alvotech shares jump after FDA accepts Entyvio biosimilar application for review (ALVO)
- Jun 8th, 2026 4:41 am
Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio®
- Jun 8th, 2026 2:00 am
How The Investment Story For Alvotech (ALVO) Is Shifting Without New Analyst Guidance
- Jun 6th, 2026 8:12 pm
Alvotech (ALVO) Receives FDA Form 483 Following Routine Facility Inspection
- Jun 6th, 2026 9:44 am
ALVO Stock Gains 19% on FDA Resubmission of Biosimilar BLAs
- Jun 5th, 2026 11:31 am
Alvotech Nears Inflection Point With 5 U.S. Biosimilars Targeted by Year-End
- Jun 4th, 2026 10:02 pm
Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi® and Simponi Aria®, and AVT06, a proposed biosimilar to Eylea®
- Jun 4th, 2026 2:00 am
Alvotech to present at upcoming investor conferences in June
- Jun 2nd, 2026 2:30 pm
Alvotech (ALVO) Q4 2025 Earnings Transcript
- Jun 2nd, 2026 11:17 am
Alvotech and Islandsbanki renew Market Making Agreement for ALVO Shares Trading on Nasdaq Iceland
- Jun 1st, 2026 2:30 am
Alvotech Plans June FDA Resubmissions, Sees Biosimilar Approvals by Year-End
- May 13th, 2026 6:13 pm
Alvotech Announces Completion of FDA Surveillance Inspection at Reykjavik Facility
- May 11th, 2026 2:30 am
Alvotech (ALVO) Q1 2026 Earnings Transcript
- May 8th, 2026 9:17 am
Alvotech’s Earnings Swing And Counsel Exit Might Change The Case For Investing In ALVO
- May 7th, 2026 9:15 pm
Alvotech Q1 Earnings Call Highlights
- May 7th, 2026 7:22 am
Alvotech (ALVO) Reports Q1 Loss, Lags Revenue Estimates
- May 6th, 2026 7:45 pm
Alvotech Q1 2026 Financial Results
- May 6th, 2026 2:30 pm
Alvotech Announces a Change in its Executive Team
- Apr 30th, 2026 2:30 pm
Alvotech (ALVO) Valuation Gap Under Review After Mixed Share Performance And Biosimilar Pipeline Progress
- Apr 26th, 2026 12:06 am
Scroll